Western Financial Corp’s Alnylam Pharmaceuticals ALNY Stock Holding History

Western Financial Corp’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$910K	Buy	3,023 +157	+5%	+$47.4K	0.27%	68
2026 Q1	$948K	Buy	2,866 +135	+5%	+$45.9K	0.37%	55
2025 Q4	$1.09M	Buy	2,731 +7	+0.3%	+$3.1K	0.43%	55
2025 Q3	$1.24M	Buy	+2,724	New	+$1.11M	0.54%	48
2023 Q3	–	Sell	-3,630	Closed	-$689K	–	107
2023 Q2	$689K	Buy	3,630 +654	+22%	+$130K	0.47%	65
2023 Q1	$596K	Buy	2,976 +196	+7%	+$41.2K	0.42%	78
2022 Q4	$661K	Buy	2,780 +189	+7%	+$40.3K	0.43%	57
2022 Q3	$519K	Buy	+2,591	New	+$494K	0.36%	72

Other funds holding ALNY

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

FAF

Fjarde Ap-fonden Stockholm, Sweden $20.9B AUM 36.93% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Western Financial Corp's ALNY Position: Q2 2026 in Review

Western Financial Corp increased its Alnylam Pharmaceuticals (ALNY) stake by 5.5% in Q2 2026, buying an estimated $47.4K and bringing the position to 3,023 shares worth $910K. The position accounts for 0.27% of the portfolio, ranked #68.

Western Financial Corp first reported a position in ALNY in Q3 2022 and has held it in 8 quarters since. The position peaked at $1.24M in Q3 2025. 247 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

Western Financial Corp held 3,023 shares of Alnylam Pharmaceuticals worth $910K as of Q2 2026.
Western Financial Corp bought 157 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $47.4K.
Alnylam Pharmaceuticals made up 0.27% of Western Financial Corp's portfolio in Q2 2026, its #68 holding.
Western Financial Corp first reported a position in Alnylam Pharmaceuticals in Q3 2022 and has held it in 8 quarters since.
Western Financial Corp's Alnylam Pharmaceuticals position peaked at $1.24M in Q3 2025.
247 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Western Financial Corp's 13F filing for Q2 2026, filed 22 Jul 2026.